Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema SANTA CLARA, Calif. , January 16, 2020 Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children... Read more
Agilent Expands Cross-Vendor CDS Instrument Control SANTA CLARA, Calif. , January 02, 2020 Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can choose a chromatography data system from either company—Agilent OpenLab CDS or Thermo Fisher Chromeleon—to control analytical... Read more
Agilent Compliance Services Voted No. 1 in Global Survey SANTA CLARA, Calif. , December 30, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey. Cell Associates conducted a survey for Agilent Technologies to the readers... Read more
Agilent Ranked Among Top Four Best Workplaces in Greater China and Receives Certification as a Best Workplace for Women in Greater China SANTA CLARA, Calif., December 6, 2019 Agilent Technologies, Inc. (NYSE: A) today announced it has been selected as one of the top four “Best Workplaces™ in Greater China” by the Great Place to... Read more
https://www.agilent.com/about/newsroom/presrel/2019/03dec-ca19029.html Read more
Agilent Receives Multiple Life Science Industry Awards for Innovation Recognizing innovation and excellence in the life science industry SANTA CLARA, Calif., November 26, 2019 Agilent Technologies, Inc. (NYSE: A) announced today that it has received two Life Science Industry Awards (LSIA) for ‘Most Innovative New Products in 2019’ from BioInformatics Inc. Since 2002, the LSIA... Read more
https://www.agilent.com/about/newsroom/presrel/2019/25nov-gp19026.html Read more
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) in Europe SANTA CLARA, Calif., November 22, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that its PD-L1... Read more
Agilent Announces Applications Open for LabCentral Golden Ticket Sponsorship will enable a promising biotech startup to advance scientific discovery SANTA CLARA, Calif., November 21, 2019 Agilent Technologies, Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and biotech startup... Read more
Agilent Technologies Increases Cash Dividendto 18 Cents Per Share SANTA CLARA, Calif., November 20, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 18 cents per share of common stock, reflecting a 10 percent increase over the previous quarter’s dividend. The dividend will be... Read more